51 related articles for article (PubMed ID: 17982125)
1. Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials.
Playford RJ; Cattell M; Marchbank T
PLoS One; 2020; 15(6):e0234719. PubMed ID: 32555629
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.
Wang GP; Xu CS
World J Gastrointest Pathophysiol; 2010 Jun; 1(2):85-90. PubMed ID: 21607145
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair.
Marchbank T; Freeman TC; Playford RJ
Digestion; 1998; 59(3):167-74. PubMed ID: 9643675
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic secretory trypsin inhibitor as an acute phase reactant.
Ogawa M
Clin Biochem; 1988 Jan; 21(1):19-25. PubMed ID: 2449986
[TBL] [Abstract][Full Text] [Related]
5. Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.
Marchbank T; Mahmood A; Fitzgerald AJ; Domin J; Butler M; Goodlad RA; Elia G; Cox HM; van Heel DA; Ghosh S; Playford RJ
Am J Pathol; 2007 Nov; 171(5):1462-73. PubMed ID: 17982125
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2.
Marchbank T; Mahmood A; Playford RJ
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F382-9. PubMed ID: 23698120
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic secretory trypsin inhibitor is a major motogenic and protective factor in human breast milk.
Marchbank T; Weaver G; Nilsen-Hamilton M; Playford RJ
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G697-703. PubMed ID: 19147803
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
Playford RJ; Marchbank T
PLoS One; 2020; 15(1):e0227059. PubMed ID: 31923181
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing.
Turk HF; Monk JM; Fan YY; Callaway ES; Weeks B; Chapkin RS
Am J Physiol Cell Physiol; 2013 May; 304(9):C905-17. PubMed ID: 23426968
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.
Paul G; Marchelletta RR; McCole DF; Barrett KE
J Biol Chem; 2012 Jan; 287(3):2144-55. PubMed ID: 22069319
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas.
KAZAL LA; SPICER DS; BRAHINSKY RA
J Am Chem Soc; 1948 Sep; 70(9):3034-40. PubMed ID: 18882536
[No Abstract] [Full Text] [Related]
12. T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies.
Garrido G; Lorenzano P; Sánchez B; Beausoleil I; Alonso DF; Pérez R; Fernández LE
Cancer Immunol Immunother; 2007 Nov; 56(11):1701-10. PubMed ID: 17415565
[TBL] [Abstract][Full Text] [Related]
13. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice.
Ohmuraya M; Hirota M; Araki M; Mizushima N; Matsui M; Mizumoto T; Haruna K; Kume S; Takeya M; Ogawa M; Araki K; Yamamura K
Gastroenterology; 2005 Aug; 129(2):696-705. PubMed ID: 16083722
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
